![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | multiple interactions | ISO | RGD:1615724 | 6480464 | [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PLAC9 mRNA | CTD | PMID:22206623 | 17beta-estradiol | increases expression | ISO | RGD:1615724 | 6480464 | Estradiol results in increased expression of PLAC9 mRNA | CTD | PMID:19484750 | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of PLAC9 mRNA | CTD | PMID:32145629 | 2,2',5,5'-tetrachlorobiphenyl | increases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:23829299 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1615724 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PLAC9 mRNA | CTD | PMID:19933214 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PLAC9 mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PLAC9 mRNA | CTD | PMID:34747641 | 2,4,6-trinitrotoluene | affects expression | EXP | | 6480464 | Trinitrotoluene affects the expression of PLAC9 mRNA | CTD | PMID:21346803 | 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2, 4-dinitrotoluene affects the expression of PLAC9 mRNA | CTD | PMID:21346803 | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of PLAC9 mRNA | CTD | PMID:28959563 | aflatoxin B1 | decreases methylation | ISO | RGD:1315403 | 6480464 | Aflatoxin B1 results in decreased methylation of PLAC9 intron | CTD | PMID:30157460 | amitrole | increases expression | EXP | | 6480464 | Amitrole results in increased expression of PLAC9 mRNA | CTD | PMID:30047161 | antirheumatic drug | increases expression | ISO | RGD:1315403 | 6480464 | Antirheumatic Agents results in increased expression of PLAC9 mRNA | CTD | PMID:24449571 | aristolochic acid A | increases expression | ISO | RGD:1315403 | 6480464 | aristolochic acid I results in increased expression of PLAC9 mRNA | CTD | PMID:33212167 | arsane | affects expression | ISO | RGD:1315403 | 6480464 | Arsenic affects the expression of PLAC9 mRNA | CTD | PMID:18414638 | arsenic atom | affects expression | ISO | RGD:1315403 | 6480464 | Arsenic affects the expression of PLAC9 mRNA | CTD | PMID:18414638 | benzo[a]pyrene | affects methylation | ISO | RGD:1315403 | 6480464 | Benzo(a)pyrene affects the methylation of PLAC9 promoter | CTD | PMID:27901495 | benzo[a]pyrene | increases expression | ISO | RGD:1615724 | 6480464 | Benzo(a)pyrene results in increased expression of PLAC9 mRNA | CTD | PMID:32417428 | benzo[a]pyrene | increases methylation | ISO | RGD:1315403 | 6480464 | Benzo(a)pyrene results in increased methylation of PLAC9 5' UTR | CTD | PMID:27901495 | benzo[a]pyrene diol epoxide I | increases expression | ISO | RGD:1315403 | 6480464 | 7 more ... | CTD | PMID:20382639 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of PLAC9 mRNA | CTD | PMID:25181051 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of PLAC9 mRNA | CTD | PMID:32145629 | bisphenol A | increases expression | ISO | RGD:1615724 | 6480464 | bisphenol A results in increased expression of PLAC9 mRNA | CTD | PMID:30951980 | cadmium dichloride | increases expression | ISO | RGD:1615724 | 6480464 | Cadmium Chloride results in increased expression of PLAC9 mRNA | CTD | PMID:24982889 | calcitriol | decreases expression | ISO | RGD:1315403 | 6480464 | Calcitriol results in decreased expression of PLAC9 mRNA | CTD | PMID:16002434 | chromium(6+) | affects expression | ISO | RGD:1615724 | 6480464 | chromium hexavalent ion affects the expression of PLAC9 mRNA | CTD | PMID:28472532 | copper atom | decreases expression | EXP | | 6480464 | Copper results in decreased expression of PLAC9 mRNA | CTD | PMID:30556269 | copper(0) | decreases expression | EXP | | 6480464 | Copper results in decreased expression of PLAC9 mRNA | CTD | PMID:30556269 | cytarabine | decreases expression | ISO | RGD:1315403 | 6480464 | Cytarabine results in decreased expression of PLAC9 mRNA | CTD | PMID:21198554 | decabromodiphenyl ether | decreases expression | EXP | | 6480464 | decabromobiphenyl ether results in decreased expression of PLAC9 mRNA | CTD | PMID:23914054 | dorsomorphin | multiple interactions | ISO | RGD:1315403 | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLAC9 mRNA | CTD | PMID:27188386 | doxorubicin | decreases expression | ISO | RGD:1315403 | 6480464 | Doxorubicin results in decreased expression of PLAC9 mRNA | CTD | PMID:29803840 | folic acid | multiple interactions | ISO | RGD:1615724 | 6480464 | [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PLAC9 mRNA | CTD | PMID:22206623 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of PLAC9 mRNA | CTD | PMID:22061828 | methimazole | increases expression | EXP | | 6480464 | Methimazole results in increased expression of PLAC9 mRNA | CTD | PMID:30047161 | methylmercury chloride | decreases expression | ISO | RGD:1315403 | 6480464 | methylmercuric chloride results in decreased expression of PLAC9 mRNA | CTD | PMID:34089799 | oxaliplatin | increases expression | EXP | | 6480464 | oxaliplatin results in increased expression of PLAC9 mRNA | CTD | PMID:25729387 | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of PLAC9 mRNA | CTD | PMID:25729387 | ozone | multiple interactions | ISO | RGD:1615724 | 6480464 | [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of PLAC9 mRNA | CTD | PMID:34911549 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of PLAC9 mRNA | CTD | PMID:33387578 | paraquat | decreases expression | EXP | | 6480464 | Paraquat results in decreased expression of PLAC9 mRNA | CTD | PMID:32680482 | paraquat | decreases expression | ISO | RGD:1615724 | 6480464 | Paraquat results in decreased expression of PLAC9 mRNA | CTD | PMID:21371552 | resveratrol | multiple interactions | ISO | RGD:1315403 | 6480464 | [Plant Extracts co-treated with Resveratrol] results in decreased expression of PLAC9 mRNA | CTD | PMID:23557933 | SB 431542 | multiple interactions | ISO | RGD:1315403 | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLAC9 mRNA | CTD | PMID:27188386 | tetrachloromethane | affects expression | ISO | RGD:1615724 | 6480464 | Carbon Tetrachloride affects the expression of PLAC9 mRNA | CTD | PMID:17484886 | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of PLAC9 mRNA | CTD | PMID:33387578 | topotecan | increases expression | EXP | | 6480464 | Topotecan results in increased expression of PLAC9 mRNA | CTD | PMID:25729387 | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of PLAC9 mRNA | CTD | PMID:25729387 | valproic acid | decreases expression | ISO | RGD:1315403 | 6480464 | Valproic Acid results in decreased expression of PLAC9 mRNA | CTD | PMID:23179753 | valproic acid | multiple interactions | ISO | RGD:1315403 | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLAC9 mRNA | CTD | PMID:27188386 | vinclozolin | affects expression | EXP | | 6480464 | vinclozolin affects the expression of PLAC9 mRNA | CTD | PMID:19015723 | |